Efficacy of icotinib in advanced lung squamous cell carcinoma

BACKGROUND: There are controversial data supporting the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with advanced lung squamous cell carcinoma (SCC). In this study, the efficacy of icotinib in unselected and EGFR‐mutated patients with lung SCC wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Shuai, Xu, Yan, Tan, Fenlai, Ding, Lieming, Ma, Yongbin, Wang, Mengzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143949/
https://www.ncbi.nlm.nih.gov/pubmed/30109777
http://dx.doi.org/10.1002/cam4.1736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143949/
https://www.ncbi.nlm.nih.gov/pubmed/30109777
http://dx.doi.org/10.1002/cam4.1736

Ejemplares similares